Mixed results for nivolumab/ipilimumab combination in advanced kidney cancer
The results from the recent phase III CheckMate-214 clinical trial [...]
New immuno-oncology treatment to be tested in solid tumours
A new immuno-oncology treatment made by British company, Biotecnol, is about to [...]
How treatments have changed for advanced or metastatic renal cell carcinoma (RCC) over the past decade and a look at potential new treatments for the future
During the last decade, the treatment of advanced or metastatic [...]
NICE turns down two kidney cancer drugs
NICE has issued draft guidance this week turning down two [...]
Call to transform cancer services to improve survival rates in Wales
The following article by the BBC reported that 300 more [...]
Initiation of phase 2 clinical trial of glutaminase inhibitor plus everolimus for renal cell carcinoma
Calithera Biosciences, an American pharmaceutical company focused on developing drugs [...]
Banks to offer financial help to cancer patients
For a large proportion of patients ringing the Macmillan helpline, [...]
MicroRNA as a potential biomarker for kidney cancer
Recently, researchers are focusing on microRNAs (miRNAs) circulating in the [...]
Current treatment of advanced papillary renal cell carcinoma
Despite significant improvements in the treatment outcomes of clear cell [...]
UK cancer survival rates lag behind other European countries
A recent study, commissioned by the Association of the British Pharmaceutical [...]
